P16 Expression in cutaneous squamous carcinomas with neck metastases: A potential pitfall in identifying unknown primaries of the head and neck

Head and Neck

Volumn 35, Issue 11, 2013, Pages 1527-1533

  Beadle, Beth M ^a   William Jr , William N ^a   McLemore, Michael S ^a   Sturgis, Erich M ^a   Williams, Michelle D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cutaneous squamous carcinoma; neck metastases; p16; unknown primary

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MALE; NECK METASTASIS; OROPHARYNX TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA;

CUTANEOUS SQUAMOUS CARCINOMA; NECK METASTASES; P16; UNKNOWN PRIMARY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, UNKNOWN PRIMARY; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886412490     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23188     Document Type: Article

References (31)

1. Dahlstrom KR, Adler-Storthz K, Etzel CJ, et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 2003; 9: 2620-2626.
2. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636.
3. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
4. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
5. Schache AG, Liloglou T, Risk JM, et al. Evaluation of human papillomavirus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011; 17: 6262-6271.
6. Gillison ML,. HPV and prognosis for patients with oropharynx cancer. Eur J Cancer 2009; 45 Suppl 1: 383-385.
7. Harris SL, Thorne LB, Seaman WT, Hayes DN, Couch ME, Kimple RJ,. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2011; 33: 1622-1627.
8. Ai L, Stephenson KK, Ling W, et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol 2003; 16: 944-950.
9. Geisler SA, Olshan AF, Weissler MC, et al. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002; 8: 3445-3453.
10. Fischer CA, Kampmann M, Zlobec I, et al. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010; 21: 1961-1966.
11. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010; 28: 4142-4148.
12. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH,. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003; 9: 6469-6475.
13. Begum S, Gillison ML, Nicol TL, Westra WH,. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13: 1186-1191.
14. Weiss D, Koopmann M, Rudack C,. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck 2011; 33: 856-862.
15. Li W, Thompson CH, Cossart YE, et al. The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer. Mod Pathol 2004; 17: 1031-1037.
16. Conscience I, Jovenin N, Coissard C, et al. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol 2006; 16: 518-522.
17. Hodges A, Smoller BR,. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 2002; 15: 1121-1125.
18. Küsters-Vandevelde HV, Van Leeuwen A, Verdijk MA, et al. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. Int J Cancer 2010; 126: 2123-2132.
19. Cardoso JC, Calonje E,. Cutaneous manifestations of human papillomaviruses: a review. Acta Dermatovenerol Alp Panonica Adriat 2011; 20: 145-154.
20. Romagosa C, Simonetti S, López-Vicente L, et al. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene 2011; 30: 2087-2097.
21. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T,. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-1748.
22. Pereira TC, Share SM, Magalhães AV, Silverman JF,. Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases. Appl Immunohistochem Mol Morphol 2011; 19: 10-14.
23. Duray A, Descamps G, Arafa M, et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol 2011; 39: 51-59.
24. Harris SL, Thorne LB, Seaman WT, Hayes DN, Couch ME, Kimple RJ,. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2011; 33: 1622-1627.
25. Lo EJ, Bell D, Woo JS, et al. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 2010; 120: 1990-1997.
26. Doxtader EE, Katzenstein AL,. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol 2012; 43: 327-332.
27. Randall DA, Johnstone PA, Foss RD, Martin PJ,. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 2000; 122: 52-55.
28. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ, DeSanto LW,. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992; 23: 743-749.
29. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP,. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001; 50: 55-63.
30. Barker CA, Morris CG, Mendenhall WM,. Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site. Am J Clin Oncol 2005; 28: 445-448.
31. Desai PC, Jaglal MV, Gopal P, et al. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study. Exp Mol Pathol 2009; 87: 94-98.